$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] An interactive retrieval system for clinical trial studies with context-dependent protocol elements 원문보기

PloS one, v.15 no.9, 2020년, pp.e0238290 -   

Park, Junseok (Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea) ,  Park, Seongkuk (Information & Electronics Research Institute, Daejeon, Republic of Korea) ,  Kim, Kwangmin (Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea) ,  Hwang, Woochang (The Milner Institute, University of Cambridge, Cambridge, United Kingdom) ,  Yoo, Sunyong (School of Electronics and Computer Engineering, Chonnam National University, Gwangju, Republic of Korea) ,  Yi, Gwan-su (Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea) ,  Lee, Doheon (Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

A well-defined protocol for a clinical trial guarantees a successful outcome report. When designing the protocol, most researchers refer to electronic databases and extract protocol elements using a keyword search. However, state-of-the-art database systems only offer text-based searches for user-en...

참고문헌 (75)

  1. 1 Tay-Teo K. , Ilbawi A. , and Hill S. R. , " Comparison of sales income and research and development costs for fda-approved cancer drugs sold by originator drug companies ," JAMA network open , vol. 2 , no. 1 , pp. e186875 ? e186875 , 2019 10.1001/jamanetworkopen.2018.6875 30644967 

  2. 2 G. V. Research. "Clinical Trials Market Size Worth $68.9 Billion By 2026 | CAGR: 5.7%." https://www.grandviewresearch.com/press-release/clinical-trials-market (accessed 2019). 

  3. 3 Chan A.-W. et al , " SPIRIT 2013 statement: defining standard protocol items for clinical trials ," vol. 158 , no. 3 , pp. 200 ? 207 , 2013 10.7326/0003-4819-158-3-201302050-00583 23295957 

  4. 4 Getz K. A. , Wenger J. , Campo R. A. , Seguine E. S. , and Kaitin K. I. J. A. j. o. t. , " Assessing the impact of protocol design changes on clinical trial performance ," vol. 15 , no. 5 , pp. 450 ? 457 , 2008 10.1097/MJT.0b013e31816b9027 18806521 

  5. 5 Claerhout B. et al , " Federated electronic health records research technology to support clinical trial protocol optimization: Evidence from EHR4CR and the InSite platform ," Journal of Biomedical Informatics , vol. 90 , p. 103090 , 2019/02/01/ 2019 , 10.1016/j.jbi.2018.12.004 30611012 

  6. 6 Getz K. A. , Zuckerman R. , Cropp A. B. , Hindle A. L. , Krauss R. , and Kaitin K. I. J. D. I. J. , " Measuring the incidence, causes, and repercussions of protocol amendments ," vol. 45 , no. 3 , pp. 265 ? 275 , 2011 . 

  7. 7 Malikova M. A. , " Optimization of protocol design: a path to efficient, lower cost clinical trial execution ," Future science OA , vol. 2 , no. 1 , 2016 . 

  8. 8 Getz K. A. et al , " The impact of protocol amendments on clinical trial performance and cost ," vol. 50 , no. 4 , pp. 436 ? 441 , 2016 10.1177/2168479016632271 30227022 

  9. 9 Rodrigues L. M. L. et al , " Towards a standardized protocol for conducting randomized clinical trial for software ," Procedia computer science , vol. 138 , pp. 125 ? 130 , 2018 . 

  10. 10 Park Y. R. et al , " Utilization of a Clinical Trial Management System for the Whole Clinical Trial Process as an Integrated Database: System Development ," J Med Internet Res , vol. 20 , no. 4 , p. e103 , 4 24 2018 , 10.2196/jmir.9312 29691212 

  11. 11 Tetzlaff J. M. , Moher D. , and Chan A. W. , " Developing a guideline for clinical trial protocol content: Delphi consensus survey ," Trials , vol. 13 , p. 176 , 9 24 2012 , 10.1186/1745-6215-13-176 23006145 

  12. 12 Silberschatz A. , Korth H. F. , and Sudarshan S. , Database system concepts . McGraw-Hill New York , 1997 . 

  13. 13 Cambridge U. , " Introduction to information retrieval ," 2009 . 

  14. 14 Steeves J. et al , "Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures," vol. 45 , no. 3 , p. 206 , 2007 10.1038/sj.sc.3102008 17179972 

  15. 15 Tsatsaronis G. et al , "PONTE: a context-aware approach for automated clinical trial protocol design," in proceedings of the 6th International Workshop on Personalized Access , Profile Management , and Context Awareness in Databases in conjunction with VLDB , 2012 . 

  16. 16 Tasneem A. et al , "The database for aggregate analysis of ClinicalTrials. gov (AACT) and subsequent regrouping by clinical specialty," vol. 7 , no. 3 , p. e33677 , 2012 10.1371/journal.pone.0033677 22438982 

  17. 17 Griesenauer R. H. , Schillebeeckx C. , and Kinch M. S. , " CDEK: Clinical Drug Experience Knowledgebase ," Database , vol. 2019 , 2019 . 

  18. 18 Zarin D. A. and Keselman A. J. C. , " Registering a clinical trial in ClinicalTrials. gov ," vol. 131 , no. 3 , pp. 909 ? 912 , 2007 10.1378/chest.06-2450 17303677 

  19. 19 Canese K. and Weis S. , "PubMed: the bibliographic database," in The NCBI Handbook [Internet] 2nd edition : National Center for Biotechnology Information (US) , 2013 . 

  20. 20 Tasneem A. et al , "The database for aggregate analysis of ClinicalTrials. gov (AACT) and subsequent regrouping by clinical specialty," PloS one , vol. 7 , no. 3 , p. e33677 , 2012 [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306288/pdf/pone.0033677.pdf . 10.1371/journal.pone.0033677 22438982 

  21. 21 De Gruttola V. G. et al , " Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials ," Controlled Clinical Trials , vol. 22 , no. 5 , pp. 485 ? 502 , 2001/10/01/ 2001 , 10.1016/s0197-2456(01)00153-2 11578783 

  22. 22 Neves M. L. , Carazo J.-M. , and Pascual-Montano A. , " Moara: a Java library for extracting and normalizing gene and protein mentions ," BMC bioinformatics , vol. 11 , no. 1 , p. 157 , 2010 . 20346105 

  23. 23 Pence H. E. and Williams A. , " ChemSpider: an online chemical information resource ," ed: ACS Publications , 2010 . 

  24. 24 Savova G. K. et al , "Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications," Journal of the American Medical Informatics Association , vol. 17 , no. 5 , pp. 507 ? 513 , 2010 10.1136/jamia.2009.001560 20819853 

  25. 25 Hulley S. B. , Designing clinical research Lippincott Williams & Wilkins , 2007 . 

  26. 26 Meeker-O’Connell A. et al , " Enhancing clinical evidence by proactively building quality into clinical trials ," vol. 13 , no. 4 , pp. 439 ? 444 , 2016 10.1177/1740774516643491 27098014 

  27. 27 Aggett P. J. et al , " Passclaim ," vol. 44 , pp. i5 ? i30 , 2005 10.1007/s00394-005-1104-3 15933809 

  28. 28 Kok F. J. and Kromhout D. J. E. j. o. n. , " Atherosclerosis ," vol. 43 , no. 1 , pp. i2 ? i5 , 2004 . 

  29. 29 Mensink R. P. et al , " PASSCLAIM?Diet-related cardiovascular disease ," vol. 42 , no. 1 , pp. i6 ? i27 , 2003 . 

  30. 30 Cummings J. H. et al , " PASSCLAIM 1―gut health and immunity ," vol. 43 , no. 2 , pp. ii118 ? ii173 , 2004 . 

  31. 31 Adams A. S. , Soumerai S. B. , Lomas J. , and Ross-Degnan D. J. I. J. f. Q. i. H. C. , " Evidence of self-report bias in assessing adherence to guidelines ," vol. 11 , no. 3 , pp. 187 ? 192 , 1999 10.1093/intqhc/11.3.187 10435838 

  32. 32 Google, "Google scholar," 2019. [Online]. Available: https://scholar.google.com/ . 

  33. 33 P.-. NCBI, "National Center for Biotechnology Information," 2019. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/ . 

  34. 34 Clarivate, "Web of Science," 2019. [Online]. Available: https://apps.webofknowledge.com . 

  35. 35 Elsevier, "Scopus," 2019. [Online]. Available: https://www.scopus.com/search/form.uri . 

  36. 36 DeCandia G. et al , " Dynamo: amazon's highly available key-value store ," in ACM SIGOPS operating systems review , 2007 , vol. 41 , no. 6 : ACM, pp. 205 ? 220 . 

  37. 37 Bodenreider O. J. N. a. r. , "The unified medical language system (UMLS): integrating biomedical terminology," vol. 32 , no. suppl_1 , pp. D267 ? D270 , 2004 . 

  38. 38 Krallinger M. , Leitner F. , Rabal O. , Vazquez M. , Oyarzabal J. , and Valencia A. J. J. o. c. , " CHEMDNER: The drugs and chemical names extraction challenge ," vol. 7 , no. 1 , p. S1 , 2015 . 

  39. 39 Li J. et al , " DOSim: an R package for similarity between diseases based on disease ontology ," vol. 12 , no. 1 , p. 266 , 2011 . 

  40. 40 Mathur S. and Dinakarpandian D. J. S. o. T. B. , " Automated ontological gene annotation for computing disease similarity ," vol. 2010 , p. 12 , 2010 21347137 

  41. 41 Savova G. K. et al , "Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications," vol. 17 , no. 5 , pp. 507 ? 513 , 2010 10.1136/jamia.2009.001560 20819853 

  42. 42 De Gruttola V. G. et al , " Considerations in the evaluation of surrogate endpoints in clinical trials: summary of a National Institutes of Health workshop ," vol. 22 , no. 5 , pp. 485 ? 502 , 2001 10.1016/s0197-2456(01)00153-2 11578783 

  43. 43 Y. Xia et al., "Combining MetaMap and cTAKES in Disorder Recognition: THCIB at CLEF eHealth Lab 2013 Task 1," in CLEF (Working Notes) , 2013. 

  44. 44 Rocktaschel T. , Weidlich M. , and Leser U. J. B. , " ChemSpot: a hybrid system for chemical named entity recognition ," vol. 28 , no. 12 , pp. 1633 ? 1640 , 2012 10.1093/bioinformatics/bts183 22500000 

  45. 45 Heller S. , McNaught A. , Stein S. , Tchekhovskoi D. , and Pletnev I. J. J. o. c. , " InChI-the worldwide chemical structure identifier standard ," vol. 5 , no. 1 , p. 7 , 2013 10.1186/1758-2946-5-7 23343401 

  46. 46 Chambers J. et al , " UniChem: a unified chemical structure cross-referencing and identifier tracking system ," vol. 5 , no. 1 , p. 3 , 2013 10.1186/1758-2946-5-3 23317286 

  47. 47 Neves M. L. , Carazo J.-M. , and Pascual-Montano A. J. B. b. , " Moara: a Java library for extracting and normalizing gene and protein mentions ," vol. 11 , no. 1 , p. 157 , 2010 . 

  48. 48 Getz K. A. and Campo R. A. , " Trial watch: trends in clinical trial design complexity ," ed: Nature Publishing Group , 2017 . 

  49. 49 Getz K. A. , Kim J. , Stergiopoulos S. , Kaitin K. I. J. T. i. , and r. science, "New governance mechanisms to optimize protocol design," vol. 47 , no. 6 , pp. 651 ? 655 , 2013 . 

  50. 50 Tian Y. and Patel J. M. , " Tale: A tool for approximate large graph matching ," in 2008 IEEE 24th International Conference on Data Engineering , 2008 : IEEE , pp. 963 ? 972 . 

  51. 51 Tong H. , Faloutsos C. , Faloutsos C. , Gallagher B. , and Eliassi-Rad T. , " Fast best-effort pattern matching in large attributed graphs ," in Proceedings of the 13th ACM SIGKDD international conference on Knowledge discovery and data mining , 2007 : ACM , pp. 737 ? 746 . 

  52. 52 Tilkov S. and Vinoski S. J. I. I. C. , " Node. js: Using JavaScript to build high-performance network programs ," vol. 14 , no. 6 , pp. 80 ? 83 , 2010 . 

  53. 53 M. J. U. h. d. j. o. Bostock , " D3. js-data-driven documents (2016) ," 2016 . 

  54. 54 Hausler J. , " 4 Major Patterns for Accessible Drag and Drop ," 2018 [Online]. Available: https://medium.com/salesforce-ux/4-major-patterns-for-accessible-drag-and-drop-1d43f64ebf09 . 

  55. 55 Andrews S. and Hirsch L. , " A tool for creating and visualising formal concept trees ," in CEUR Workshop Proceedings , 2016 , vol. 1637 : Tilburg University , pp. 1 ? 9 . 

  56. 56 Morisset C. and Sanchez D. , " VisABAC: A Tool for Visualising ABAC Policies ," in ICISSP , 2018 , pp. 117 ? 126 . 

  57. 57 Maarek Y. S. , Vortman P. , and Wecker A. J. , " Interactive, tree structured, graphical visualization aid ," ed: Google Patents , 1999 . 

  58. 58 Chow S.-C. and Liu J.-p. , Design and analysis of clinical trials: concepts and methodologies John Wiley & Sons , 2008 . 

  59. 59 Storer B. E. J. B. , " Design and analysis of phase I clinical trials ," vol. 45 , no. 3 , pp. 925 ? 937 , 1989 2790129 

  60. 60 Pocock S. J. J. B. M. J. , " Current issues in the design and interpretation of clinical trials ," vol. 290 , no. 6461 , pp. 39 ? 42 , 1985 10.1136/bmj.290.6461.39 3917328 

  61. 61 U. S. N. L. o. Medicine, "Clinical Trial Registry Numbers in MEDLINE/PubMed Records," 2019. [Online]. Available: https://www.nlm.nih.gov/bsd/policy/clin_trials.html . 

  62. 62 Goutte C. and Gaussier E. , " A probabilistic interpretation of precision, recall and F-score, with implication for evaluation ," in European Conference on Information Retrieval , 2005 : Springer , pp. 345 ? 359 . 

  63. 63 Likert R. J. A. o. p. , " A technique for the measurement of attitudes ," 1932 . 

  64. 64 I. H. T. J. J. P. M. Guideline, " Guideline for good clinical practice ," vol. 47 , no. 3 , pp. 199 ? 203 , 2001 11832625 

  65. 65 Brown E. G. , Wood L. , and Wood S. J. D. s. , " The medical dictionary for regulatory activities (MedDRA) ," vol. 20 , no. 2 , pp. 109 ? 117 , 1999 10.2165/00002018-199920020-00002 10082069 

  66. 66 Fung K. W. , Hole W. T. , Nelson S. J. , Srinivasan S. , Powell T. , and Roth L. J. J. o. t. A. M. I. A. , " Integrating SNOMED CT into the UMLS: an exploration of different views of synonymy and quality of editing ," vol. 12 , no. 4 , pp. 486 ? 494 , 2005 10.1197/jamia.M1767 15802483 

  67. 67 Robinson P. N. , Kohler S. , Bauer S. , Seelow D. , Horn D. , and Mundlos S. J. T. A. J. o. H. G. , " The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease ," vol. 83 , no. 5 , pp. 610 ? 615 , 2008 10.1016/j.ajhg.2008.09.017 18950739 

  68. 68 Schirle M. and Jenkins J. L. J. D. d. t. , " Identifying compound efficacy targets in phenotypic drug discovery ," vol. 21 , no. 1 , pp. 82 ? 89 , 2016 10.1016/j.drudis.2015.08.001 26272035 

  69. 69 Iskar M. , Zeller G. , Zhao X.-M. , van Noort V. , and Bork P. J. C. o. i. b. , " Drug discovery in the age of systems biology: the rise of computational approaches for data integration ," vol. 23 , no. 4 , pp. 609 ? 616 , 2012 10.1016/j.copbio.2011.11.010 22153034 

  70. 70 Cheng F. , Kovacs I. A. , and Barabasi A.-L. , " Network-based prediction of drug combinations ," Nature Communications , vol. 10 , no. 1 , p. 1197 , 2019/03/13 2019 , 10.1038/s41467-019-09186-x 30867426 

  71. 71 Guney E. , Menche J. , Vidal M. , and Barabasi A.-L. J. N. c. , " Network-based in silico drug efficacy screening ," vol. 7 , p. 10331 , 2016 10.1038/ncomms10331 26831545 

  72. 72 Hopkins A. L. J. N. c. b. , " Network pharmacology: the next paradigm in drug discovery ," vol. 4 , no. 11 , p. 682 , 2008 10.1038/nchembio.118 18936753 

  73. 73 van Hasselt J. C. and Iyengar R. , " Systems pharmacology: defining the interactions of drug combinations ," Annual review of pharmacology and toxicology , vol. 59 , pp. 21 ? 40 , 2019 10.1146/annurev-pharmtox-010818-021511 30260737 

  74. 74 Park J. , Kim K. , Hwang W. , and Lee D. , " Concept embedding to measure semantic relatedness for biomedical information ontologies ," Journal of biomedical informatics , vol. 94 , p. 103182 , 2019 10.1016/j.jbi.2019.103182 31009761 

  75. 75 McFee B. and Lanckriet G. R. , " Metric learning to rank ," in Proceedings of the 27th International Conference on Machine Learning (ICML-10) , 2010 , pp. 775 ? 782 . 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로